Realta Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,985
Closed -$220K 356
2025
Q3
$220K Sell
1,985
-241
-11% -$27.4K 0.07% 182
2025
Q2
$247K Sell
2,226
-650
-23% -$69.2K 0.1% 157
2025
Q1
$322K Sell
2,876
-792
-22% -$81.7K 0.15% 131
2024
Q4
$335K Sell
3,668
-495
-12% -$44.6K 0.14% 131
2024
Q3
$354K Sell
4,163
-2,613
-39% -$199K 0.16% 131
2024
Q2
$465K Buy
6,776
+912
+16% +$60.9K 0.09% 239
2024
Q1
$430K Buy
5,864
+890
+18% +$68.4K 0.09% 259
2023
Q4
$403K Buy
4,974
+114
+2% +$8.87K 0.09% 252
2023
Q3
$375K Sell
4,860
-400
-8% -$30.8K 0.09% 253
2023
Q2
$405K Buy
5,260
+1,220
+30% +$97.3K 0.09% 249
2023
Q1
$335K Sell
4,040
-1,467
-27% -$122K 0.08% 274
2022
Q4
$473K Buy
5,507
+177
+3% +$14K 0.12% 215
2022
Q3
$329K Buy
5,330
+1,409
+36% +$88.8K 0.09% 258
2022
Q2
$245K Buy
3,921
+443
+13% +$27.4K 0.06% 305
2022
Q1
$207K Sell
3,478
-193
-5% -$12.3K 0.04% 388
2021
Q4
$267K Buy
3,671
+364
+11% +$25.1K 0.06% 334
2021
Q3
$231K Sell
3,307
-2
-0.1% -$141 0.05% 352
2021
Q2
$228K Sell
3,309
-33
-1% -$2.2K 0.05% 350
2021
Q1
$216K Buy
+3,342
New +$215K 0.06% 339
2020
Q3
Sell
-5,717
Closed -$440K 336
2020
Q2
$440K Buy
5,717
+1,876
+49% +$144K 0.14% 186
2020
Q1
$287K Sell
3,841
-2,079
-35% -$144K 0.12% 212
2019
Q4
$398K Buy
5,920
+1,554
+36% +$101K 0.11% 217
2019
Q3
$274K Sell
4,366
-1,205
-22% -$78.8K 0.07% 271
2019
Q2
$377K Buy
5,571
+19
+0.3% +$1.25K 0.1% 216
2019
Q1
$367K Buy
+5,552
New +$369K 0.17% 179

Other funds holding GILD

Realta Investment Advisors's GILD Position: Q4 2025 in Review

Realta Investment Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 1,985 shares — an estimated $220K sold.

Realta Investment Advisors first reported a position in GILD in Q1 2019 and held it in 25 quarters. The position peaked at $473K in Q4 2022. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Realta Investment Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Realta Investment Advisors sold 1,985 Gilead Sciences shares in Q4 2025, an estimated $220K.
  • Realta Investment Advisors first reported a position in Gilead Sciences in Q1 2019 and held it in 25 quarters.
  • Realta Investment Advisors's Gilead Sciences position peaked at $473K in Q4 2022.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Realta Investment Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.